ZA201001683B - Substituted piperidino-dihydrothienopyrimidines - Google Patents

Substituted piperidino-dihydrothienopyrimidines

Info

Publication number: ZA201001683B
Authority: ZA; South Africa
Prior art keywords: dihydrothienopyrimidines; substituted piperidino; piperidino; substituted
Prior art date: 2007-10-19

Application number

ZA201001683A

Other languages

English (en)

Inventor

Pascale Pouzet

Ralf Anderskewitz

Horst Dollinger

Dennis Fiegen

Thomas Fox

Original Assignee

Boehringer Ingelheim Int

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2007-10-19

Filing date

2010-03-09

Publication date

2010-10-27

Family has litigation

First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=39154006&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=ZA201001683(B) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.

2010-03-09 Application filed by Boehringer Ingelheim Int filed Critical Boehringer Ingelheim Int

2010-10-27 Publication of ZA201001683B publication Critical patent/ZA201001683B/xx

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D495/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms
- C07D495/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms in which the condensed system contains two hetero rings
- C07D495/04—Ortho-condensed systems
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/08—Drugs for disorders of the alimentary tract or the digestive system for nausea, cinetosis or vertigo; Antiemetics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/02—Nasal agents, e.g. decongestants
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/06—Antiasthmatics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/08—Bronchodilators
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/10—Expectorants
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/12—Mucolytics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/04—Centrally acting analgesics, e.g. opioids
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
- A61P25/16—Anti-Parkinson drugs
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/22—Anxiolytics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A61P35/02—Antineoplastic agents specific for leukemia
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/08—Antiallergic agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/04—Inotropic agents, i.e. stimulants of cardiac contraction; Drugs for heart failure
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D519/00—Heterocyclic compounds containing more than one system of two or more relevant hetero rings condensed among themselves or condensed with a common carbocyclic ring system not provided for in groups C07D453/00 or C07D455/00

Landscapes

Health & Medical Sciences (AREA)
Chemical & Material Sciences (AREA)
Organic Chemistry (AREA)
Engineering & Computer Science (AREA)
Bioinformatics & Cheminformatics (AREA)
Life Sciences & Earth Sciences (AREA)
Veterinary Medicine (AREA)
General Chemical & Material Sciences (AREA)
Medicinal Chemistry (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Chemical Kinetics & Catalysis (AREA)
Pharmacology & Pharmacy (AREA)
Public Health (AREA)
Animal Behavior & Ethology (AREA)
General Health & Medical Sciences (AREA)
Neurosurgery (AREA)
Biomedical Technology (AREA)
Neurology (AREA)
Pulmonology (AREA)
Cardiology (AREA)
Hospice & Palliative Care (AREA)
Pain & Pain Management (AREA)
Psychiatry (AREA)
Immunology (AREA)
Heart & Thoracic Surgery (AREA)
Otolaryngology (AREA)
Rheumatology (AREA)
Oncology (AREA)
Dermatology (AREA)
Psychology (AREA)
Orthopedic Medicine & Surgery (AREA)
Physical Education & Sports Medicine (AREA)
Hematology (AREA)
Gastroenterology & Hepatology (AREA)
Ophthalmology & Optometry (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
Plural Heterocyclic Compounds (AREA)
Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

ZA201001683A 2007-10-19 2010-03-09 Substituted piperidino-dihydrothienopyrimidines ZA201001683B (en)

Applications Claiming Priority (1)

Application Number	Priority Date	Filing Date	Title
EP07118901		2007-10-19

Publications (1)

Publication Number	Publication Date
ZA201001683B true ZA201001683B (en)	2010-10-27

Family

ID=39154006

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
ZA201001683A ZA201001683B (en)	2007-10-19	2010-03-09	Substituted piperidino-dihydrothienopyrimidines

Country Status (34)

Country	Link
US (1)	US8754073B2 (xx)
EP (3)	EP2610258B1 (xx)
JP (2)	JP5150728B2 (xx)
KR (1)	KR101548975B1 (xx)
CN (2)	CN104069112A (xx)
AR (1)	AR069075A1 (xx)
AT (1)	ATE542825T1 (xx)
AU (1)	AU2008313660B2 (xx)
BR (1)	BRPI0818006B8 (xx)
CA (1)	CA2705414C (xx)
CL (1)	CL2008003096A1 (xx)
CY (2)	CY1112703T1 (xx)
DK (2)	DK2215092T3 (xx)
EA (1)	EA019480B1 (xx)
EC (1)	ECSP10010156A (xx)
ES (2)	ES2381452T3 (xx)
HK (1)	HK1145677A1 (xx)
HR (2)	HRP20120334T1 (xx)
MA (1)	MA31845B1 (xx)
ME (1)	ME01330B (xx)
MX (1)	MX2010004026A (xx)
MY (1)	MY153979A (xx)
NZ (1)	NZ585346A (xx)
PE (2)	PE20091386A1 (xx)
PL (2)	PL2215092T3 (xx)
PT (2)	PT2610258E (xx)
RS (1)	RS52271B (xx)
SI (2)	SI2215092T1 (xx)
TN (1)	TN2010000175A1 (xx)
TW (1)	TWI421077B (xx)
UA (1)	UA99309C2 (xx)
UY (1)	UY31405A1 (xx)
WO (1)	WO2009050248A1 (xx)
ZA (1)	ZA201001683B (xx)

Families Citing this family (35)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
EP1847543A1 (de)	2006-04-19	2007-10-24	Boehringer Ingelheim Pharma GmbH & Co. KG	Dihydrothienopyrimidine zur Behandlung von entzündlichen Erkrankungen
NZ584962A (en) *	2007-10-18	2011-07-29	Boehringer Ingelheim Int	Preparation of dihydrothieno [3, 2-d] pyrimidines and intermediates used therein
ATE537175T1 (de)	2007-10-19	2011-12-15	Boehringer Ingelheim Int	Neue piperazino-dihydrothienopyrimidin-derivate
ME01330B (me) *	2007-10-19	2013-12-20	Boehringer Ingelheim Int	Supstituisani piperidino-dihidrotienopirimidini
RU2500681C2 (ru) *	2007-10-19	2013-12-10	Берингер Ингельхайм Интернациональ Гмбх	Замещенные гетероциклом пиперазинодигидротиенопиримидины
EP2400962B1 (de)	2009-02-27	2017-11-08	Boehringer Ingelheim International GmbH	Arzneimittelkombinationen enthaltend pde4-inhibitoren und nsaids
JP2013529184A (ja)	2010-04-08	2013-07-18	ベーリンガーインゲルハイムインターナショナルゲゼルシャフトミットベシュレンクテルハフツング	Ｐｄｅ４阻害剤及びｅｐ４受容体アンタゴニストを含有する医薬の組み合わせ
WO2011124525A1 (de)	2010-04-08	2011-10-13	Boehringer Ingelheim International Gmbh	Arnzeimittelkombinationen enthaltend pde4-inhibitoren und ep4-rezeptor-antagonisten
EP2568812B1 (en) *	2010-05-11	2016-10-26	Merck Sharp & Dohme Corp.	Novel prolylcarboxypeptidase inhibitors
US20130059866A1 (en)	2011-08-24	2013-03-07	Boehringer Ingelheim International Gmbh	Novel piperidino-dihydrothienopyrimidine sulfoxides and their use for treating copd and asthma
US9802954B2 (en)	2011-08-24	2017-10-31	Boehringer Ingelheim International Gmbh	Piperidino-dihydrothienopyrimidine sulfoxides and their use for treating COPD and asthma
US9013997B2 (en) *	2012-06-01	2015-04-21	Broadcom Corporation	System for performing distributed data cut-through
US9499519B2 (en)	2012-12-26	2016-11-22	Medivation Technologies, Inc.	Fused pyrimidine compounds and use thereof
MX2015009677A (es)	2013-02-04	2015-11-25	Gruenenthal Gmbh	Compuestos de pirimidina condensada sustituida novedosos.
WO2014124860A1 (en)	2013-02-14	2014-08-21	Boehringer Ingelheim International Gmbh	Specific pde4b-inhibitors for the treatment of diabetes mellitus
HUP1300139A2 (en) *	2013-03-06	2014-09-29	Richter Gedeon Nyrt	Phenoxypiperidine h3 antagonists
CN104892720B (zh) *	2014-03-07	2016-10-26	华东师范大学	4,4-二甲基石胆酸-2,3-骈n-芳基吡唑衍生物及其制备方法和应用
ES2874185T3 (es) *	2016-06-30	2021-11-04	Riken	Nuevo compuesto o una sal farmacéuticamente aceptable del mismo
EP3684775A1 (en) *	2017-09-20	2020-07-29	Leo Pharma A/S	Substituted dihydrothienopyrimidines and their use as phosphodiesterase inhibitors
IL309150B1 (en)	2017-10-23	2024-11-01	Boehringer Ingelheim Int Gmbh	A new combination of active substances for the treatment of advanced interstitial and lymphoid lung diseases
ES2968822T3 (es)	2017-12-15	2024-05-14	Union Therapeutics As	Azetidina dihidrotienopirimidinas sustituidas y su uso como inhibidores de la fosfodiesterasa
WO2019115775A1 (en)	2017-12-15	2019-06-20	Leo Pharma A/S	Substituted tetrahydropyran dihydrothienopyrimidines and their use as phosphodiesterase inhibitors
EP3724196B9 (en)	2017-12-15	2023-03-22	UNION therapeutics A/S	Substituted azetidine dihydrothienopyridines and their use as phosphodiesterase inhibitors
WO2020048827A1 (en) *	2018-09-03	2020-03-12	Bayer Aktiengesellschaft	1, 3, 9-triazaspiro[5.5] undecan-2-one compounds
MX2024006271A (es)	2021-12-09	2024-06-11	Boehringer Ingelheim Int	Nuevas combinaciones terapeuticas para el tratamiento de enfermedades pulmonares intersticiales fibrosantes progresivas.
EP4426307A1 (en)	2021-12-09	2024-09-11	Boehringer Ingelheim International GmbH	New oral pharmaceutical composition and dose regimen for the therapy of progressive fibrosing interstitial lung diseases
TW202402289A (zh) *	2022-06-02	2024-01-16	大陸商西藏海思科製藥有限公司	Pde4b抑制劑及其用途
TW202408518A (zh) *	2022-06-16	2024-03-01	大陸商武漢人福創新藥物研發中心有限公司	Pde4b抑制劑
CN115040503B (zh) *	2022-07-26	2023-10-10	云南民族大学	螺环二烯酮型木脂素类化合物在制药中的应用
WO2024032673A1 (zh) *	2022-08-09	2024-02-15	西藏海思科制药有限公司	Pde4b抑制剂及其用途
WO2024068386A1 (en)	2022-09-28	2024-04-04	Boehringer Ingelheim International Gmbh	Use of biomarkers in the treatment of fibrotic conditions with a pde4b-inhibitor
WO2024067660A1 (zh) *	2022-09-29	2024-04-04	苏州爱科百发生物医药技术有限公司	氮杂稠环类化合物、其制备方法及其在医药上的应用
WO2024179493A1 (zh) *	2023-02-28	2024-09-06	上海翊石医药科技有限公司	二氢噻吩并嘧啶衍生物的制备方法和用途
WO2024208225A1 (zh) *	2023-04-03	2024-10-10	上海壹迪生物技术有限公司	二氢噻吩并嘧啶类化合物、其制备方法和应用
WO2024213089A1 (zh) *	2023-04-13	2024-10-17	上海壹迪生物技术有限公司	取代的二氢噻吩并嘧啶类化合物、其制备方法和应用

Family Cites Families (52)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
DE1470336A1 (de)	1962-07-04	1969-03-20	Thomae Gmbh Dr K	Neue Dihydrothieno-[3,4-d]-pyrimidine und Verfahren zu ihrer Herstellung
NL122810C (xx)	1963-06-17
DE1470356A1 (de)	1964-01-15	1970-04-30	Thomae Gmbh Dr K	Neue Thieno[3,2-d]pyrimidine und Verfahren zu ihrer Herstellung
NL123139C (xx)	1965-03-31
DE2032687A1 (en)	1970-07-02	1972-01-05	Dr. Karl Thomae Gmbh, 7950 Biberach	Cardiovascular 2-aminoalkylamino-thienopyrimidines - and 4-morpholino derivatives from 4-diethanolamino-compounds by intramolecular cyclisa
DE1940572A1 (de)	1969-08-08	1971-02-11	Thomae Gmbh Dr K	Neue 2-Aminoalkylamino-thieno[3,2-d]pyrimidine und Verfahren zu ihrer Herstellung
BE754606A (fr) *	1969-08-08	1971-02-08	Thomae Gmbh Dr K	Nouvelles 2-aminoalcoylamino-thieno(3,2-d)pyrimidines et leurs procedesde fabrication
US3763156A (en) *	1970-01-28	1973-10-02	Boehringer Sohn Ingelheim	2-heterocyclic amino-4-morpholinothieno(3,2-d)pyrimidines
FR2082496A5 (xx)	1970-03-18	1971-12-10	Westinghouse Freins & Signaux
DE2121950A1 (en)	1971-05-04	1972-11-23	Dr. Karl Thomae Gmbh, 7950 Biberach	Thieno(3,2-d)pyrimidine derivs - with thrombocyte aggregation inhibiting activity
DE2750288A1 (de) *	1977-11-10	1979-05-17	Thomae Gmbh Dr K	Neue 9-(omega-heteroarylamino- alkylamino)-erythromycine, ihre salze, verfahren zu ihrer herstellung und diese enthaltende arzneimittel
US4256737A (en) *	1979-06-11	1981-03-17	Syntex (U.S.A.) Inc.	Long acting depot injectable formulations for LH-RH analogues
US5187168A (en) *	1991-10-24	1993-02-16	American Home Products Corporation	Substituted quinazolines as angiotensin II antagonists
US5491201A (en)	1992-02-06	1996-02-13	The Dow Chemical Company	Mesogenic cyclic imino ether-containing compositions and polymerization products thereof
JPH07330777A (ja)	1994-06-08	1995-12-19	Taisho Pharmaceut Co Ltd	チエノ［３，２−ｄ］ピリミジン−４−オン誘導体
JPH09301958A (ja)	1996-05-09	1997-11-25	Nippon Shoji Kk	新規ピリミジン化合物及び抗ロタウイルス剤
US6339089B2 (en)	1997-08-13	2002-01-15	Fujirebio Inc.	Pyrimidine nucleus-containing compound and a medicament containing the same for a blood oxygen partial pressure amelioration, and a method for preparing the same
JP2003520042A (ja)	2000-01-24	2003-07-02	アイシス・ファーマシューティカルス・インコーポレーテッド	誘導性一酸化窒素シンターゼ発現のアンチセンスモジュレーション
GB0004153D0 (en)	2000-02-23	2000-04-12	Astrazeneca Uk Ltd	Novel use
CN1221549C (zh)	2000-10-12	2005-10-05	贝林格尔英格海姆法玛两合公司	结晶单水合物、其制备方法及其在制备药物组合中的用途
DE10064994A1 (de)	2000-12-23	2002-07-04	Merck Patent Gmbh	Sulfamidothienopyrimidine
US6849638B2 (en)	2001-04-30	2005-02-01	Bayer Pharmaceuticals Corporation	4-amino-5,6-substituted thiopheno [2,3-d] pyrimidines, pharmaceutical compositions containing the same, and their use in the treatment or prevention of pde7b-mediated diseases and conditions
AR035700A1 (es)	2001-05-08	2004-06-23	Astrazeneca Ab	Derivados de arilheteroalquilamina, composicion farmaceutica, usos de estos derivados para la fabricacion de medicamentos, metodos de tratamiento, y proceso para la preparacion de estos derivados
EA005813B1 (ru)	2001-06-22	2005-06-30	Бёрингер Ингельхайм Фарма Гмбх Унд Ко. Кг	Безводный кристаллический тиотропийбромид, способ его получения и его применение для получения лекарственного средства
US6587548B2 (en) *	2001-07-17	2003-07-01	Hewlett-Packard Development Co., L.P.	Method and system of using a single telephone number for multiple services
AU2002364211A1 (en)	2001-12-21	2003-07-15	Bayer Pharmaceuticals Corporation	Thienopyrimidine derivative compounds as inhibitors of prolylpeptidase, inducers of apoptosis and cancer treatment agents
US20040014755A1 (en)	2002-01-10	2004-01-22	Dhanapalan Nagarathnam	Rho-kinase inhibitors
SE0203304D0 (sv)	2002-11-07	2002-11-07	Astrazeneca Ab	Novel Coumpounds
AU2004234158B2 (en)	2003-04-29	2010-01-28	Pfizer Inc.	5,7-diaminopyrazolo[4,3-D]pyrimidines useful in the treatment of hypertension
US20050084878A1 (en)	2003-05-16	2005-04-21	Wisconsin Alumni Research Foundation	Method for isolating and cloning high molecular weight polynucleotide molecules from the environment
JP2005003345A (ja)	2003-05-21	2005-01-06	Showa Denko Kk	換気兼熱交換装置および空調システム
ES2454196T3 (es) *	2003-10-02	2014-04-09	Dsm Ip Assets B.V.	Producción de niveles altos de DHA en microalgas utilizando cantidades modificadas de cloruro y potasio
MY141220A (en)	2003-11-17	2010-03-31	Astrazeneca Ab	Pyrazole derivatives as inhibitors of receptor tyrosine kinases
US20050137186A1 (en)	2003-12-18	2005-06-23	Abbott Gmbh & Co. Kg.	Tetrahydrobenzazepines and their use
DK1701951T3 (da)	2003-12-23	2010-06-07	Serodus As	Modulatorer af perifere 5-HT receptorer
WO2005082865A1 (ja)	2004-02-27	2005-09-09	Astellas Pharma Inc.	縮合二環性ピリミジン誘導体
GB0427403D0 (en)	2004-12-15	2005-01-19	Astrazeneca Ab	Novel compounds I
CN101163706A (zh) *	2005-04-21	2008-04-16	贝林格尔·英格海姆国际有限公司	用于治疗炎性疾病的二氢噻吩并嘧啶
MX2007013766A (es)	2005-05-11	2008-01-28	Nycomed Gmbh	Combinacion de inhibidor pde4 de roflumilast y un derivado de tetrahidrobiopterina.
EP1847543A1 (de) *	2006-04-19	2007-10-24	Boehringer Ingelheim Pharma GmbH & Co. KG	Dihydrothienopyrimidine zur Behandlung von entzündlichen Erkrankungen
SI2137196T1 (sl)	2007-04-20	2011-01-31	Glaxo Group Ltd Glaxo Welcome House	Tricikliäśne spojine, ki vsebujejo duĺ ik, uporabne kot antibakterijska sredstva
NZ584962A (en)	2007-10-18	2011-07-29	Boehringer Ingelheim Int	Preparation of dihydrothieno [3, 2-d] pyrimidines and intermediates used therein
FR2922550B1 (fr) *	2007-10-19	2009-11-27	Sanofi Aventis	Nouveaux derives de 6-aryl/heteroalkyloxy benzothiazole et benzimidazole, application comme medicaments, compositions pharmaceutiques et nouvelle utilisation notamment comme inhibiteurs de cmet
PE20091349A1 (es) *	2007-10-19	2009-09-07	Schering Corp	Compuestos derivados de espiro 1,3,4-tiadiazol como inhibidores de la actividad quinesina ksp
ATE537175T1 (de) *	2007-10-19	2011-12-15	Boehringer Ingelheim Int	Neue piperazino-dihydrothienopyrimidin-derivate
RU2500681C2 (ru)	2007-10-19	2013-12-10	Берингер Ингельхайм Интернациональ Гмбх	Замещенные гетероциклом пиперазинодигидротиенопиримидины
WO2009051556A1 (en) *	2007-10-19	2009-04-23	Astrazeneca Ab	Tetrazole derivatives as modulators of metabotropic glutamate receptors (mglurs)
ME01330B (me) *	2007-10-19	2013-12-20	Boehringer Ingelheim Int	Supstituisani piperidino-dihidrotienopirimidini
CA2702447A1 (en) *	2007-10-19	2009-04-30	Boehringer Ingelheim International Gmbh	New phenyl-substituted piperazino-dihydrothienopyrimidines
EP2400961B1 (de) *	2009-02-27	2017-11-22	Boehringer Ingelheim International GmbH	Arzneimittelkombinationen enthaltend pde4-inhibitoren und nsaids
EP2400962B1 (de) *	2009-02-27	2017-11-08	Boehringer Ingelheim International GmbH	Arzneimittelkombinationen enthaltend pde4-inhibitoren und nsaids
US20130059866A1 (en) *	2011-08-24	2013-03-07	Boehringer Ingelheim International Gmbh	Novel piperidino-dihydrothienopyrimidine sulfoxides and their use for treating copd and asthma

2008
- 2008-10-16 ME MEP-2012-26A patent/ME01330B/me unknown
- 2008-10-16 MY MYPI2010001693A patent/MY153979A/en unknown
- 2008-10-16 US US12/738,344 patent/US8754073B2/en active Active
- 2008-10-16 JP JP2010529389A patent/JP5150728B2/ja active Active
- 2008-10-16 EA EA201000609A patent/EA019480B1/ru not_active IP Right Cessation
- 2008-10-16 DK DK08839793.0T patent/DK2215092T3/da active
- 2008-10-16 AT AT08839793T patent/ATE542825T1/de active
- 2008-10-16 PL PL08839793T patent/PL2215092T3/pl unknown
- 2008-10-16 ES ES08839793T patent/ES2381452T3/es active Active
- 2008-10-16 PT PT131547903T patent/PT2610258E/pt unknown
- 2008-10-16 KR KR1020107010905A patent/KR101548975B1/ko active IP Right Grant
- 2008-10-16 WO PCT/EP2008/063999 patent/WO2009050248A1/de active Application Filing
- 2008-10-16 UA UAA201005780A patent/UA99309C2/ru unknown
- 2008-10-16 PL PL13154790T patent/PL2610258T3/pl unknown
- 2008-10-16 DK DK13154790.3T patent/DK2610258T3/da active
- 2008-10-16 SI SI200830579T patent/SI2215092T1/sl unknown
- 2008-10-16 EP EP13154790.3A patent/EP2610258B1/de active Active
- 2008-10-16 ES ES13154790.3T patent/ES2524910T3/es active Active
- 2008-10-16 PT PT08839793T patent/PT2215092E/pt unknown
- 2008-10-16 BR BRPI0818006A patent/BRPI0818006B8/pt active IP Right Grant
- 2008-10-16 MX MX2010004026A patent/MX2010004026A/es active IP Right Grant
- 2008-10-16 CA CA2705414A patent/CA2705414C/en active Active
- 2008-10-16 NZ NZ585346A patent/NZ585346A/en unknown
- 2008-10-16 CN CN201410312258.5A patent/CN104069112A/zh active Pending
- 2008-10-16 EP EP11174754.9A patent/EP2380891B1/de active Active
- 2008-10-16 RS RS20120144A patent/RS52271B/en unknown
- 2008-10-16 EP EP08839793A patent/EP2215092B1/de active Active
- 2008-10-16 AU AU2008313660A patent/AU2008313660B2/en active Active
- 2008-10-16 SI SI200831314T patent/SI2610258T1/sl unknown
- 2008-10-16 CN CN200880112254.5A patent/CN101827852B/zh active Active
- 2008-10-17 CL CL2008003096A patent/CL2008003096A1/es unknown
- 2008-10-17 PE PE2008001796A patent/PE20091386A1/es not_active Application Discontinuation
- 2008-10-17 AR ARP080104560A patent/AR069075A1/es active IP Right Grant
- 2008-10-17 UY UY31405A patent/UY31405A1/es not_active Application Discontinuation
- 2008-10-17 TW TW097139983A patent/TWI421077B/zh active
- 2008-10-17 PE PE2013001391A patent/PE20131463A1/es not_active Application Discontinuation
2010
- 2010-03-09 ZA ZA201001683A patent/ZA201001683B/xx unknown
- 2010-04-16 TN TN2010000175A patent/TN2010000175A1/fr unknown
- 2010-05-05 EC EC2010010156A patent/ECSP10010156A/es unknown
- 2010-05-12 MA MA32832A patent/MA31845B1/fr unknown
- 2010-12-22 HK HK10111978.1A patent/HK1145677A1/xx not_active IP Right Cessation
2012
- 2012-04-16 HR HRP20120334AT patent/HRP20120334T1/hr unknown
- 2012-04-23 CY CY20121100378T patent/CY1112703T1/el unknown
- 2012-12-03 JP JP2012264647A patent/JP5615889B2/ja active Active
2014
- 2014-11-26 CY CY20141100984T patent/CY1115858T1/el unknown
- 2014-11-26 HR HRP20141153AT patent/HRP20141153T1/hr unknown

Also Published As

Publication number	Publication date
NZ585346A (en)	2011-09-30
CN104069112A (zh)	2014-10-01
ECSP10010156A (es)	2010-06-29
JP2013064001A (ja)	2013-04-11
MY153979A (en)	2015-04-30
HK1145677A1 (en)	2011-04-29
US8754073B2 (en)	2014-06-17
PL2215092T3 (pl)	2012-07-31
EA201000609A1 (ru)	2010-10-29
TW200918074A (en)	2009-05-01
JP5150728B2 (ja)	2013-02-27
KR101548975B1 (ko)	2015-09-01
CY1115858T1 (el)	2017-01-25
JP2011500640A (ja)	2011-01-06
PE20131463A1 (es)	2013-12-23
UY31405A1 (es)	2009-05-29
CL2008003096A1 (es)	2010-02-12
AU2008313660B2 (en)	2013-11-07
ES2381452T3 (es)	2012-05-28
WO2009050248A1 (de)	2009-04-23
EP2215092A1 (de)	2010-08-11
CA2705414C (en)	2016-05-24
PE20091386A1 (es)	2009-10-17
EP2610258A1 (de)	2013-07-03
AU2008313660A1 (en)	2009-04-23
BRPI0818006B8 (pt)	2021-05-25
DK2215092T3 (da)	2012-05-07
JP5615889B2 (ja)	2014-10-29
US20110021501A1 (en)	2011-01-27
PT2215092E (pt)	2012-04-10
ME01330B (me)	2013-12-20
ES2524910T3 (es)	2014-12-15
ATE542825T1 (de)	2012-02-15
HRP20120334T1 (hr)	2012-05-31
CN101827852B (zh)	2014-07-30
EP2215092B1 (de)	2012-01-25
MA31845B1 (fr)	2010-11-01
AR069075A1 (es)	2009-12-30
CA2705414A1 (en)	2009-04-23
SI2215092T1 (sl)	2012-04-30
CY1112703T1 (el)	2016-02-10
BRPI0818006B1 (pt)	2019-10-22
EA019480B1 (ru)	2014-04-30
DK2610258T3 (da)	2014-11-10
BRPI0818006A2 (pt)	2015-12-22
MX2010004026A (es)	2010-04-30
RS52271B (en)	2012-10-31
TWI421077B (zh)	2014-01-01
KR20100100807A (ko)	2010-09-15
EP2610258B1 (de)	2014-08-27
UA99309C2 (xx)	2012-08-10
HRP20141153T1 (hr)	2015-02-13
TN2010000175A1 (fr)	2011-11-11
PT2610258E (pt)	2014-10-24
SI2610258T1 (sl)	2014-12-31
EP2380891A1 (de)	2011-10-26
PL2610258T3 (pl)	2015-02-27
EP2380891B1 (de)	2013-12-11
CN101827852A (zh)	2010-09-08

Publication	Publication Date	Title
IL202616A0 (en)	2010-06-30	Substituted imidazoheterocycles
ZA201001683B (en)	2010-10-27	Substituted piperidino-dihydrothienopyrimidines
DE602008005470D1 (en)	2011-04-21	Imidazopyridinone
EP2160187A4 (en)	2011-08-03	SPIROINDALONE
AP2010005314A0 (en)	2010-08-31	Nanodispersian
GB0701437D0 (en)	2007-03-07	Electro-chlorinator
IL200965A0 (en)	2010-06-16	Substituted tetrahydropyrroloquinolines
DE602008004135D1 (en)	2011-02-03	Triphenylmethan- und xanthenpigmente
GB0701606D0 (en)	2007-03-07	Adjustachair
GB0700595D0 (en)	2007-02-21	Holecutter
AU3613P (en)	2008-09-19	LS005A01 Leucospermum cuneiforme
AU3606P (en)	2008-09-16	Jaywick xTriticosecale
AU3595P (en)	2008-09-12	Goldust Strobilanthes anisophyllus
AU3642P (en)	2008-12-02	TAS100 Dianella tasmanica
AU3646P (en)	2008-12-02	TAS300 Dianella tasmanica
AU3702P (en)	2009-01-08	DarwinGold Dianella ensifolia
AU3952P (en)	2009-12-23	FLOCHRDEF Chrysocephalum apiculatum
ZA201000435B (en)	2010-10-27	Substituted imidazoheterocycles
GB0700852D0 (en)	2007-02-21	Visi-hitch
AU318847S (en)	2008-04-15	Cordless-multi-cutter
GB0700234D0 (en)	2007-02-14	Mobi-hold
GB0700248D0 (en)	2007-02-14	Pro-tiler
GB0701419D0 (en)	2007-03-07	Barbi-keg
GB0700292D0 (en)	2007-02-14	Cpmpounds
GB0700298D0 (en)	2007-02-14	Pramstand